Ongoing Clinical Trials Ongoing Clinical Trials

Ongoing Clinical Trials

Home >> Clinical Trial Guidance >> Ongoing Clinical Trials

We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.

* Protocol No. KM-01
* Research Title A phase II study of avelumab in patients with mismatch repair deficient or POLE mutated metastatic colorectal cancer
* Overall Research Director Kim Tae Won Affiliate Seoul Asan Medical Center
Carcinoma MSI-H Metastatic colorectal cancer
Target Gene MSI Clinical Trial Drug Avelumab
Research period 2017.11.01 ~ 2021.12.31 Progress Status complete
Number of recipients 33 / 33 Registration rate 100%

Institutional research participation

No. Research manager Research institution

:: There is no registered research participant information. ::

prev list next

arrow Method of participation

If you want to participate in the clinical examination, please contact the email address below.

Email kmaster@korea.ac.kr | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562